908 Devices Stock Today
| MASS Stock | USD 4.11 0.21 4.86% |
PerformanceOK
| Odds Of DistressLow
|
908 Devices is selling for under 4.11 as of the 17th of March 2025; that is 4.86 percent decrease since the beginning of the trading day. The stock's lowest day price was 4.1. 908 Devices has about a 20 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat ok performance during the last 90 days. The performance scores are derived for the period starting the 17th of December 2024 and ending today, the 17th of March 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 18th of December 2020 | Category Healthcare | Classification Health Care |
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company has 35.33 M outstanding shares of which 2.28 M shares are now shorted by private and institutional investors with about 8.13 trading days to cover. More on 908 Devices
Moving against 908 Stock
908 Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Thematic Idea | Drugs (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Drugs, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Levels908 Devices can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand 908 Devices' financial leverage. It provides some insight into what part of 908 Devices' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
908 Devices (MASS) is traded on NASDAQ Exchange in USA. It is located in 645 Summer Street, Boston, MA, United States, 02210 and employs 246 people. 908 Devices is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 145.21 M. 908 Devices conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 35.33 M outstanding shares of which 2.28 M shares are now shorted by private and institutional investors with about 8.13 trading days to cover.
908 Devices currently holds about 212.99 M in cash with (30.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.74, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check 908 Devices Probability Of Bankruptcy
Ownership Allocation908 Devices secures a total of 35.33 Million outstanding shares. Over half of 908 Devices' outstanding shares are owned by institutions. These institutions are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company retains, if the real value of the entity is less than the current market value, you may not be able to make money on it.
Check 908 Ownership Details
908 Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Dimensional Fund Advisors, Inc. | 2024-12-31 | 384.3 K | |
| Renaissance Technologies Corp | 2024-12-31 | 295 K | |
| Morgan Stanley - Brokerage Accounts | 2024-12-31 | 266.6 K | |
| Goldman Sachs Group Inc | 2024-12-31 | 264.3 K | |
| Sands Capital Ventures, Llc | 2024-12-31 | 237.3 K | |
| Charles Schwab Investment Management Inc | 2024-12-31 | 201.8 K | |
| Northern Trust Corp | 2024-12-31 | 200.8 K | |
| Needham Investment Management, Llc | 2024-12-31 | 200 K | |
| Citadel Advisors Llc | 2024-12-31 | 197.2 K | |
| Ark Investment Management Llc | 2024-12-31 | 2.8 M | |
| Blackrock Inc | 2024-12-31 | 1.9 M |
908 Devices Historical Income Statement
908 Stock Against Markets
908 Devices Corporate Management
| Kevin Knopp | CEO, CoFounder | Profile | |
| Joseph IV | CFO Treasurer | Profile | |
| Steve Araiza | CoFounder | Profile | |
| Scott Miller | Cofounder Engineering | Profile | |
| JD Esq | Chief Secretary | Profile |
Additional Tools for 908 Stock Analysis
When running 908 Devices' price analysis, check to measure 908 Devices' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 908 Devices is operating at the current time. Most of 908 Devices' value examination focuses on studying past and present price action to predict the probability of 908 Devices' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 908 Devices' price. Additionally, you may evaluate how the addition of 908 Devices to your portfolios can decrease your overall portfolio volatility.